Neoadjuvant Chemoradiotherapy vesus Chemotherapy alone Followed by Surgery for Resectable Stage III Non-Small-Cell Lung Cancer: a Meta-Analysis.
Neoadjuvant Chemotherapy has been used for the stage III of non-small cell lung cancer (NSCLC) and has shown good clinical effects. However, the survival benefits of radiation therapy added in induction regimens remains controversial. We therefore conducted a meta-analysis of the published clinical trials to quantitatively evaluate the benefit of preoperative chemoradiotherapy. After searching the database of Pubmed, CNKI, EMBASE, ESMO, The Cochrane Library databases, The American Society of Clinical Oncology and Clinical Trials.gov. Trials were selected for meta-analysis if they provided an independent assessment of neoadjuvant chemoradiation and neoadjuvant chemotherapy, odds ratio(OR) for tumor downstaging, mediastinal lymph nodes pathological complete response and local control, hazard ratios (HRs) for 5-year survival and progression-free survival were pooled by the stata software version 12.0. Twelve studies involving 2,724 patients were identified, tumor downstaging (p = 0.01), mediastinal lymph nodes pathological complete responses (p = 0.028) and local control (P = 0.002) were achieved, when compared with neoadjuvant chemotherapy. The meta-analysis demonstrated neither 5-year survival nor progression-free-survival benefit in survival from adding radiation. In conclusion, the addition of radiotherapy into chemotherapy was not superior to neoadjuvant chemotherapy. The higher quality of trials need be investigated combining with the histopathological type and genotyping of lung cancer by clinicians.
Department of Internal Medicine 2, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, 330029, China.
Shan Xian
SX
Guo
Department of Internal Medicine 2, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, 330029, China.|Medical College of Nanchang University, Nanchang, Jiangxi Province, 330006, China.
Yan
Y
Jian
Department of Internal Medicine 2, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, 330029, China.
Ying Lan
YL
Chen
Department of Internal Medicine 2, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, 330029, China.
Yun
Y
Cai
Department of Internal Medicine 2, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, 330029, China.
Qing Yuan
QY
Zhang
Department of Internal Medicine 2, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, 330029, China.|Medical College of Nanchang University, Nanchang, Jiangxi Province, 330006, China.
Fang Fang
FF
Tou
Anticancer Drugs. 2015 Nov;26(10):1083-8
26339936
J Thorac Cardiovasc Surg. 2015 Dec;150(6):1484-92; discussion 1492-3
26259994
Cancer. 2012 Dec 15;118(24):6126-35
22674529
Chest. 2005 Jul;128(1):452-62
16002972
Ann Thorac Med. 2009 Oct;4(4):201-7
19881166
Ann Thorac Surg. 2012 Jun;93(6):1807-12
22632486
Stat Med. 1998 Dec 30;17(24):2815-34
9921604
Lung Cancer. 2006 Dec;54(3):325-9
16987564
Eur J Cancer. 2014 Nov;50(17):2939-49
25304298
Ann Thorac Surg. 2014 Oct;98(4):1184-91
25110336
Mol Clin Oncol. 2015 May;3(3):706-712
26137291
Case Rep Oncol. 2014 Oct 23;7(3):700-10
25493083
J Cancer. 2015 Sep 15;6(11):1172-8
26516366
Chest. 2013 May;143(5 Suppl):e314S-40S
23649445
Clin Lung Cancer. 2016 Jan;17 (1):75-9
26387039
Eur J Cancer. 1996 Oct;32A(11):1893-900
8943671
Ann Thorac Surg. 2013 May;95(5):1708-16
23545194
Lung Cancer. 2010 Jul;69(1):86-93
19879013
EBioMedicine. 2015 Jun 19;2(8):841-50
26425690
BMC Cancer. 2015 May 06;15:363
25943191
J Thorac Oncol. 2016 Apr;11(4):537-44
26724474
Ann Thorac Surg. 2015 Jul;100(1):207-13; discussion 213-4
26047995
Eur J Cardiothorac Surg. 2005 Jun;27(6):1092-8
15896624
Interact Cardiovasc Thorac Surg. 2012 Dec;15(6):954-60
22976995
Biostatistics. 2002 Dec;3(4):445-57
12933591
Lancet. 2015 Sep 12;386(9998):1049-56
26275735
Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1462-7
19467798
Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):307-16
25838187
Lancet Oncol. 2008 Jul;9(7):636-48
18583190
J Natl Cancer Inst. 2014 Jul 29;106(8):null
25074417
J Thorac Dis. 2015 Sep;7(9):1616-23
26543609
Eur J Cardiothorac Surg. 2013 Dec;44(6):1117-22
23543202